Literature DB >> 16197398

Onset of flexural psoriasis during infliximab treatment for Crohn's disease.

L Peramiquel, L Puig, J Dalmau, E Ricart, E Roe, A Alomar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16197398     DOI： 10.1111/j.1365-2230.2005.01882.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  6 in total

Review 1.  Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

Authors:  Isabelle Cleynen; Séverine Vermeire
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

2.  Repeated Paradoxical Aggravation of Preexisting Psoriasis during Infliximab Treatment for Crohn's Disease.

Authors:  Byung Cheol Park; Hyun Jung Lim; Byung Soo Kim; Weon Ju Lee; Do Won Kim; Seok-Jong Lee
Journal:  Ann Dermatol       Date:  2009-02-28       Impact factor: 1.444

3.  Study of Molecular Mechanisms Involved in the Pathogenesis of Immune-Mediated Inflammatory Diseases, using Psoriasis As a Model.

Authors:  E S Piruzian; V V Sobolev; R M Abdeev; A D Zolotarenko; A A Nikolaev; M K Sarkisova; M E Sautin; A A Ishkin; An L Piruzyan; S A Ilyina; I M Korsunskaya; O Y Rahimova; S A Bruskin
Journal:  Acta Naturae       Date:  2009-10       Impact factor: 1.845

4.  Infliximab-induced intertriginous psoriasis in patient with Crohn's disease.

Authors:  Federica Mola; Alberico Motolese
Journal:  Dermatol Reports       Date:  2011-10-03

5.  Paradoxical SAPHO syndrome observed during anti-TNFα therapy for Crohn's disease.

Authors:  Hitoshi Amano; Reikei Matsuda; Tomohiko Shibata; Daisuke Takahashi; Shinichiro Suzuki
Journal:  Biologics       Date:  2017-05-22

6.  The changing face of spondyloarthropathies under TNF α blockade.

Authors:  Ori Elkayam; Irena Litinsky; David Levartovsky; Dan Caspi
Journal:  Open Rheumatol J       Date:  2008-11-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.